Eriksson BI, Dahl OE, Rosencher N., et al; RE-NOVATE Study Group.Dabigatrin etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomized double-blind, non-inferiority trial . Lancet. 2007;370:949-956.
2.
Amadeus Investigators, Bousser MG, Bouthier J., Buller HR, et al. Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomized, open-label, non inferiority trial. Lancet. 2008371:315-321.
3.
Hirsh J., O'Donnell M., Eikelboom JWBeyond unfractionated heparin and warfarin: current and future advances. Circulation. 2007;116:552-560.
